Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 4/20 | 0.36 |
| ▸ | CNR2 | P34972 | 4/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ACLY | P53396 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | HEXA | P06865 | 1/20 | 0.35 |
| ▸ | HEXB | P07686 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10054054 | 0.80 | EGFR (0.36) | ALDH1A1MAPK1ACHEL3MBTL1MAPT | |
| SCHEMBL10054157 | 0.72 | CYP2A6 (0.39) | ALDH1A1MEN1KMT2ATP53MAPT | |
| SCHEMBL233427 | 0.71 | CNR2 (0.42) | ALDH1A1MEN1KMT2AENPP1ACHE | |
| SCHEMBL28003132 | 0.71 | ALDH1A1 (0.42) | ALDH1A1MAPK1MEN1KMT2AENPP1 | |
| SCHEMBL13319606 | 0.71 | ALDH1A1 (0.50) | ALDH1A1MAPK1MEN1KMT2AACHE | |
| SCHEMBL20240244 | 0.70 | ALOX5 (0.34) | — | |
| SCHEMBL28530288 | 0.69 | SNCA (0.50) | ALDH1A1MAPK1MEN1KMT2AACHE | |
| SCHEMBL9612423 | 0.69 | MAPK1 (0.43) | ALDH1A1MAPK1KMT2AENPP1ACHE | |
| SCHEMBL14198895 | 0.69 | ALDH1A1 (0.39) | ALDH1A1MAPK1MEN1KMT2AENPP1 | |
| SCHEMBL488939 | 0.69 | ACHE (0.50) | ALDH1A1MAPK1KMT2AENPP1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2588527-B1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL IND LTD (JP) | 2017-10-25 | — | — | EP | disclosed |
| EP-2588527-B1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL IND LTD (JP) | 2017-10-25 | — | — | EP | disclosed |
| US-20170186953-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170186953-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170186953-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-9577194-B2 | Hole transport compositions and related devices and methods (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-02-21 | — | — | US | disclosed |
| US-9577194-B2 | Hole transport compositions and related devices and methods (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-02-21 | — | — | US | disclosed |
| US-9577194-B2 | Hole transport compositions and related devices and methods (I) | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-02-21 | — | — | US | disclosed |
| US-9112157-B2 | Hole transport materials including OLED applications | SOLVAY USA, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-9112157-B2 | Hole transport materials including OLED applications | SOLVAY USA, INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-8535974-B2 | Hole transport compositions and related devices and methods (II) | PLEXTRONICS, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| US-8535974-B2 | Hole transport compositions and related devices and methods (II) | PLEXTRONICS, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| US-8535974-B2 | Hole transport compositions and related devices and methods (II) | PLEXTRONICS, INC. (US) | 2013-09-17 | — | — | US | disclosed |
| US-20120003790-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AMD METHODS (II) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120003790-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AMD METHODS (II) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120003790-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AMD METHODS (II) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120001127-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120001127-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| US-20120001127-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | PLEXTRONICS, INC. | 2012-01-05 | — | — | US | disclosed |
| WO-2012003485-A2 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | PLEXTRONICS, INC. (US) | 2012-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120001127-A1 | HOLE TRANSPORT COMPOSITIONS AND RELATED DEVICES AND METHODS (I) | OCIAD2, OCIAD1, SLCO1B1 | ALDH1A1 1910/4885MAPK1 3107/4885MEN1 3094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.